Comparing two treatments to prevent variceal bleeding
Part of Brain & nervous system, Digestive system, Hormones & metabolism clinical trials.
This trial compares two approaches to prevent future bleeding from enlarged veins in the esophagus (food pipe) in patients with liver cirrhosis who have already had one bleeding episode. You'll receive either an endoscopic procedure with medication or a minimally invasive vein procedure, to see which works better long-term.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 75 years
- Confirmed liver cirrhosis diagnosed by biopsy, imaging, or clinical evaluation
- Recently hospitalized and treated for bleeding from esophageal varices (enlarged veins) that is now controlled
- Liver function score (Child-Pugh) between 5 and 13
- Medically stable and able to receive either treatment option
- No previous similar procedures (TIPS, surgical shunt, or vein-blocking treatments)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether placing a small tube (TIPS) at the time of variceal bleeding can prevent future bleeding in people with cirrhosis and a large clot in the liver's main vein. It aims to see if early TIPS treatment is better than standard care.
This trial tests a slightly smaller TIPS stent (underdilated) against the standard size to see which is better at preventing another variceal bleed in people with cirrhosis and liver scarring. It aims to find the safest way to lower pressure in the veins while reducing side effects.
This trial compares a surgery called LSD with a procedure called TIPS to see which is better at preventing rebleeding in people with liver cirrhosis and an enlarged spleen. It may help if you have had bleeding from veins in your esophagus or stomach that came back after treatment.
This study tests whether treating enlarged veins in the esophagus or stomach (caused by cirrhosis) in a day-care unit is safe and works well. It may help people who need repeat endoscopic treatment for these varices.
This trial compares two treatments (banding or a medication called carvedilol) to prevent the first episode of bleeding from enlarged veins in the esophagus in people with liver cancer. The goal is to find which approach is safer and more effective.
This study looks at how to best use endoscopy and other procedures to stop bleeding from enlarged veins in the esophagus or stomach caused by liver disease. It aims to find the safest and most effective treatment approach for people with this condition.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.